ProcDNA Showcases 2026 Conference Intelligence Capabilities Across Key Life Sciences Therapeutic Areas

NEWS - JUL 6, 2026

ProcDNA has unveiled its 2026 Conference Intelligence capabilities, designed to help life sciences organizations maximize the value of major scientific and medical conferences throughout the year. Covering a broad spectrum of therapeutic areas, the initiative enables pharmaceutical and biotech teams to stay ahead of emerging research, competitive developments, and evolving market dynamics.

Scientific congresses continue to play a pivotal role in shaping clinical practice, influencing treatment strategies, and driving innovation. From breakthrough clinical trial data to competitive pipeline updates, these events provide valuable opportunities for organizations to monitor trends and make informed strategic decisions.

ProcDNA's Conference Intelligence capabilities span leading events across multiple therapeutic areas, including Oncology, Neurology, Dermatology, Gynaecology, Cardiology, and Endocrinology. By combining AI-powered analytics, social listening, scientific intelligence, and competitive insights, ProcDNA helps organizations transform conference activity into actionable business intelligence.

The solution supports commercial, medical affairs, market access, and competitive intelligence teams by providing:

Real-time monitoring of conference discussions and scientific presentations.
Competitive intelligence on product pipelines, clinical trial results, and market developments.
Key Opinion Leader (KOL) tracking to identify influential voices and engagement trends.
Social listening and digital analytics to measure conference conversations and audience sentiment.
Actionable insights that support strategic planning before, during, and after major congresses.

By helping organizations prepare before conferences begin and rapidly analyze emerging developments during the events, ProcDNA enables teams to respond more effectively to changing scientific and commercial landscapes.

As the 2026 conference calendar unfolds, ProcDNA remains committed to empowering life sciences organizations with timely, data-driven intelligence that supports innovation, informed decision-making, and improved patient outcomes.